Literature DB >> 28123736

Rare virilizing granulosa cell tumor in an adolescent.

Dorottya Bús1, Mária Buzogány2, Gyöngyi Nagy3, György Vajda1.   

Abstract

Hormone-producing malignancies are rare in children or adolescent patients: Only 0.1% of all ovarian tumors and 4-5% of granulosa cell tumors occur in the sexually non-active ages. Granulosa cell tumors (GCTs) are sex cord-stromal tumors of the ovary, representing 7-8% of all ovarian neoplasms. A total of 95% of all GCTs are adult-type, and only 5% are diagnosed as juvenile-type GCT. A majority of children with juvenile-type GCT present with isosexual precocious pseudopuberty due to excessive estrogen production, although virilizing, testosterone-producing, juvenile-type GCTs are rare, occurring only in 2-3% of cases. The present case study reports on a case of a virilizing, juvenile-type GCT in a 14-year-old girl, along with a review of the literature.

Entities:  

Keywords:  adolescent; juvenile granulosa cell tumor; ovary; virilization

Year:  2016        PMID: 28123736      PMCID: PMC5245144          DOI: 10.3892/mco.2016.1084

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  11 in total

1.  [Ovulation induction therapy and malignant ovarian cancer].

Authors:  P Göcze; K Krommer; T Csermely; K Cziráky; Z Garamvölgyi; K Kovács; I Szabó
Journal:  Orv Hetil       Date:  2000-01-09       Impact factor: 0.540

2.  Ovarian steroid cell tumor, not otherwise specified, with virilization symptoms.

Authors:  Yi-Jou Tai; Wen-Chun Chang; Kuan-Ting Kuo; Bor-Ching Sheu
Journal:  Taiwan J Obstet Gynecol       Date:  2014-06       Impact factor: 1.705

3.  Patterns of spread and recurrence of sex cord-stromal tumors of the ovary.

Authors:  Melissa M Thrall; Pamela Paley; Ellen Pizer; Rochelle Garcia; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2011-04-09       Impact factor: 5.482

4.  Ovarian sex cord stromal tumours in children and young girls - a more than two decade clinicopathological experience in a developing country, Pakistan.

Authors:  Saroona Haroon; Romana Idrees; Aleena Zia; Aisha Memon; Saira Fatima; Naila Kayani
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  [Virilizing ovarian tumor in an adolescent].

Authors:  Y François; P Berlier; P Chatelain; R François
Journal:  Pediatrie       Date:  1990

Review 6.  Androgenic adult granulosa cell tumor in a teenager: a case report and review of the literature.

Authors:  C Kabaca; A Karateke; A Gurbuz; S Cesur
Journal:  Int J Gynecol Cancer       Date:  2006 Jan-Feb       Impact factor: 3.437

7.  Virilization persists in a woman with an androgen-secreting granulosa cell tumor.

Authors:  Satin S Patel; Kelley S Carrick; Bruce R Carr
Journal:  Fertil Steril       Date:  2008-12-04       Impact factor: 7.329

8.  Granulosa cell tumor in a six-year-old girl presented as precocious puberty.

Authors:  Mahin Hashemipour; Mohammad Hassan Moaddab; Masoud Nazem; Parvin Mahzouni; Mehdi Salek
Journal:  J Res Med Sci       Date:  2010-07       Impact factor: 1.852

9.  Juvenile granulosa cell tumor presenting as isosexual precocious puberty: A case report and review of literature.

Authors:  Nisha Nigil Haroon; Gaurav Agarwal; Rakesh Pandey; Preeti Dabadghao
Journal:  Indian J Endocrinol Metab       Date:  2013-01

10.  Ovarian granulosa cell tumor: An uncommon presentation with primary amenorrhea and virilization in a pubertal girl.

Authors:  Sunil Kumar Kota; Kotni Gayatri; Jaya Prakash Pani; Lalit Kumar Meher; Siva Krishna Kota; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2012-09
View more
  2 in total

1.  46, XY complete gonadal dysgenesis with pubertal virilisation due to dysgerminoma/gonadoblastoma.

Authors:  Sarah Alam; Hiya Boro; Alpesh Goyal; Rajesh Khadgawat
Journal:  BMJ Case Rep       Date:  2020-07-07

2.  A rare case report of ovarian juvenile granulosa cell tumor with massive ascites as the first sign, and review of literature: Case report and review of literature.

Authors:  Liang Ma; Liwen Zhang; Yun Zhuang; Yanbo Ding; Jianping Chen
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.